DE3681348D1 - Oral-arzneizubereitung mit retardwirkung. - Google Patents

Oral-arzneizubereitung mit retardwirkung.

Info

Publication number
DE3681348D1
DE3681348D1 DE8686304400T DE3681348T DE3681348D1 DE 3681348 D1 DE3681348 D1 DE 3681348D1 DE 8686304400 T DE8686304400 T DE 8686304400T DE 3681348 T DE3681348 T DE 3681348T DE 3681348 D1 DE3681348 D1 DE 3681348D1
Authority
DE
Germany
Prior art keywords
oral drug
drug preparation
retardive
effect
retardive effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686304400T
Other languages
English (en)
Inventor
Hiroshi Ikura
Yoshiki Suzuki
Tsuneji Nagai
Yoshiharu Machida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12513985A external-priority patent/JPS61286330A/ja
Priority claimed from JP12633785A external-priority patent/JPS61286322A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE3681348D1 publication Critical patent/DE3681348D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
DE8686304400T 1985-06-11 1986-06-10 Oral-arzneizubereitung mit retardwirkung. Expired - Lifetime DE3681348D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12513985A JPS61286330A (ja) 1985-06-11 1985-06-11 経口徐放性製剤
JP12633785A JPS61286322A (ja) 1985-06-12 1985-06-12 経口徐放性製剤

Publications (1)

Publication Number Publication Date
DE3681348D1 true DE3681348D1 (de) 1991-10-17

Family

ID=26461656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686304400T Expired - Lifetime DE3681348D1 (de) 1985-06-11 1986-06-10 Oral-arzneizubereitung mit retardwirkung.

Country Status (4)

Country Link
US (1) US4777033A (de)
EP (1) EP0205336B1 (de)
DE (1) DE3681348D1 (de)
MY (1) MY102459A (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
GB8723896D0 (en) * 1987-10-12 1987-11-18 Aps Research Ltd Controlled-release formulation
US4978534A (en) * 1987-12-12 1990-12-18 Kazuo Saitoh Gabexate mesylate ointment
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
FI894611A (fi) * 1988-09-30 1990-03-31 May & Baker Ltd Granulaera farmaceutiska preparat.
CA2006268A1 (en) * 1988-12-22 1990-06-22 Robert Z. Greenley Swelling-controlled oral delivery system for drugs
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5204114A (en) * 1992-03-30 1993-04-20 Health Maintenance Programs, Inc. Methods of manufacturing high dosage glutathione the tablets and capsules produced thereby
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5897864A (en) * 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
CA2317328C (en) * 1999-09-10 2008-01-08 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Freshness-retaining agent and method for agricultural/horticultural products
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
ATE477795T1 (de) * 2001-07-04 2010-09-15 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
DE10136781B4 (de) * 2001-07-27 2008-03-06 Lts Lohmann Therapie-Systeme Ag Flache orale Darreichungsformen mit wirkstoffhaltigen Partikeln
PT1429802E (pt) * 2001-09-28 2013-01-24 Tntgamble Inc Sistema de entrega para componente biológico
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
DE20220415U1 (de) * 2001-11-07 2003-10-09 Synthon Bv Tamsulosin-Tabletten
BR0313745A (pt) * 2002-08-23 2005-07-12 Ranbaxy Lab Ltd Apresentação farmacêutica de liberação controlada de nitrofurantoina e processo para sua preparação
WO2004024184A1 (ja) * 2002-09-11 2004-03-25 Takeda Pharmaceutical Company Limited 徐放性製剤
US20040091528A1 (en) * 2002-11-12 2004-05-13 Yamanouchi Pharma Technologies, Inc. Soluble drug extended release system
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
WO2006060672A2 (en) * 2004-12-03 2006-06-08 Dr. Reddy's Laboratories Ltd. Modified release ciprofloxacin compositions
WO2010020098A1 (zh) 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出***及其制备方法和用途
US20110171275A1 (en) * 2007-08-20 2011-07-14 Team Academy Of Pharmaceutical Science Gastroretentive drug delivery system, preparation method and use thereof
CN102349876B (zh) * 2011-10-21 2016-09-07 江西省药明扬海医药科技有限公司 一种治疗胃溃疡和十二指肠溃疡的药物及其配制方法
CN105997924A (zh) * 2016-07-07 2016-10-12 驻马店华中正大有限公司 一种盐酸金霉素泡腾片及其制备方法
CN109890371A (zh) 2016-08-26 2019-06-14 斯瑞尼瓦萨饶·韦帕切杜 组合物及其方法
DK3648747T3 (da) 2017-06-16 2022-11-28 Amneal Complex Products Res Llc Gastroretentive doseringsformer til vedvarende frigivelse af lægemidler
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
EP4056172A1 (de) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Retard-zusammensetzungen mit pyridostigmin
ES2901522T3 (es) 2018-06-27 2022-03-22 Amneal Complex Products Res Llc Sistemas de suministro de fármacos gastrorretentivos osmóticos autorregulados
EP4285895A1 (de) * 2022-06-03 2023-12-06 Adalvo Limited Orale dosierungsform von nitrofurantoin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
JPS5276418A (en) * 1975-12-19 1977-06-27 Microbial Chem Res Found Method of preparing foamable micro-capsule preparations
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration

Also Published As

Publication number Publication date
EP0205336A2 (de) 1986-12-17
US4777033A (en) 1988-10-11
EP0205336B1 (de) 1991-09-11
EP0205336A3 (en) 1987-06-03
MY102459A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
DE3681348D1 (de) Oral-arzneizubereitung mit retardwirkung.
DK546886D0 (da) Farmaceutisk praeparat
DE3688532T2 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE3650082T3 (de) Orale impfstoffe.
NO873298D0 (no) Oralt terapeutisk system med stystemisk virkning.
DE3882848D1 (de) Kosmetikbasiszubereitung mit arzneimitteleigenschaften.
FI862094A (fi) Bornerande terapeutisk komposition.
FI863077A (fi) Farmaceutisk dosenhet.
IS3339A7 (is) Ný efnablanda lyfja
DE3781034T2 (de) Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.
NL193440B (nl) Farmaceutisch preparaat met analgetische werking.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3669105D1 (de) Therapeutische zusammensetzung.
IT1213453B (it) Composizione farmaceutica.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE3682960D1 (de) Pharmazeutische praeparate.
FI860209A (fi) Engaongselektrod foer undersoekning av en patient.
IT8620985A0 (it) Imboccatura non riempibile.
NO863625D0 (no) Medikamentdoseringsanordning.
DE3675679D1 (de) Menschliche bauchspeichelelastase.
IT8520591A0 (it) Formulazione farmaceutica.
NO851435L (no) Stol.
DK499986A (da) Farmaceutisk praeparat med antibakteriel virkning
DE3667915D1 (de) Pharmazeutische zusammensetzung.
NO872843L (no) Desensitiverende dentalpreparat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee